Pages that link to "Q37325758"

The following pages link to Targeting microRNAs in pancreatic cancer: microplayers in the big game (Q37325758):

Displaying 30 items.

• Advance in microRNA as a potential biomarker for early detection of pancreatic cancer (Q28079105) (← links)
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward (Q33624574) (← links)
• Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13. (Q33671632) (← links)
• Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects (Q33801377) (← links)
• Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. (Q34157812) (← links)
• Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer (Q34177065) (← links)
• MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer (Q34365790) (← links)
• miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity (Q34422828) (← links)
• A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile (Q34664680) (← links)
• Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells (Q35130100) (← links)
• MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention? (Q35140553) (← links)
• Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. (Q35735278) (← links)
• Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract. (Q38190817) (← links)
• Emerging role of the KRAS-PDK1 axis in pancreatic cancer (Q38242805) (← links)
• microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer (Q38336073) (← links)
• The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis (Q38748123) (← links)
• Developments in miRNA gene signaling pathways in pancreatic cancer (Q38777530) (← links)
• MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. (Q38824154) (← links)
• Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathway (Q41143470) (← links)
• Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. (Q42154484) (← links)
• Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? (Q42830530) (← links)
• Alteration of the microRNA expression profile during the activation of pancreatic stellate cells. (Q54228467) (← links)
• miR-128 induces pancreas cancer cell apoptosis by targeting MDM4. (Q54986314) (← links)
• Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. (Q55445091) (← links)
• Glucocorticoid receptor regulates expression of microRNA-22 and downstream signaling pathway in apoptosis of pancreatic acinar cells (Q60046010) (← links)
• miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression. (Q64899836) (← links)
• MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation (Q89622457) (← links)
• MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential (Q90312107) (← links)
• MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma (Q90452624) (← links)
• Population-based data registries suggest novel insight into malignancy and metabolism (Q92994350) (← links)